obidoxime chloride has been researched along with Brain Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Daniels, D; Eisenkraft, A; Gilat, E; Kadar, T; Kapon, J; Krivoy, A; Last, D; Maier, S; Makarovski, I; Mardor, Y; Ramaty, E; Rosman, Y; Salomon, S; Schein, O; Shilderman, EB; Shneor, R; Shrot, S; Tamar, G | 1 |
1 other study(ies) available for obidoxime chloride and Brain Diseases
Article | Year |
---|---|
Using MRI for the assessment of paraoxon-induced brain damage and efficacy of antidotal treatment.
Topics: Animals; Antidotes; Atropine; Brain; Brain Diseases; Cholinergic Antagonists; Cholinesterase Inhibitors; Cholinesterase Reactivators; GABA Modulators; Magnetic Resonance Imaging; Male; Midazolam; Obidoxime Chloride; Paraoxon; Rats; Rats, Sprague-Dawley; Scopolamine | 2012 |